Standard BioTools Inc. (LAB)

NASDAQ: LAB · Delayed Price · USD
2.10
-0.07 (-3.23%)
At close: May 17, 2022 4:00 PM
2.01
-0.09 (-4.29%)
After-hours:May 17, 2022 5:20 PM EDT
Market Cap162.23M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out77.25M
EPS (ttm)-0.78
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume703,983
Open2.24
Previous Close2.17
Day's Range2.06 - 2.28
52-Week Range2.00 - 7.51
Beta1.14
AnalystsBuy
Price Target6.12 (+191.4%)
Earnings DateMay 5, 2022

About LAB

Fluidigm Corporation creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical i...

IndustryLife Sciences Tools & Services
IPO DateFeb 10, 2011
CEOStephen Linthwaite
Employees615
Stock ExchangeNASDAQ
Ticker SymbolLAB
Full Company Profile

Financial Performance

In 2021, LAB's revenue was $130.58 million, a decrease of -5.47% compared to the previous year's $138.14 million. Losses were -$59.24 million, 11.7% more than in 2020.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for LAB stock is "Buy." The 12-month stock price forecast is 6.12, which is an increase of 191.43% from the latest price.

Price Target
$6.12
(191.43% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Standard BioTools Announces First Quarter 2022 Financial Results

SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today announc...

1 week ago - GlobeNewsWire

Penny Stocks To Buy Now? Insiders Threw Big Money At These 4 Stocks

Penny stocks to buy according to these insiders. The post Penny Stocks To Buy Now?

Other symbols:ATAILLNWRVP
2 weeks ago - PennyStocks

Standard BioTools Announces Conference Call and Webcast of First Quarter 2022 Financial Results

SOUTH SAN FRANCISCO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today annou...

3 weeks ago - GlobeNewsWire

Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging

Capacity to Process 100-Plus Samples per Week, with 1.6x Lower Limit of Detection Capacity to Process 100-Plus Samples per Week, with 1.6x Lower Limit of Detection

1 month ago - GlobeNewsWire

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., April 05, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (f/k/a Fluidigm Corporation) (Nasdaq:FLDM) today announced, as required by Nasdaq Stock Market Rules, the grant of ...

1 month ago - GlobeNewsWire

Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.

New Trading Symbol (NASDAQ:LAB) Expected to be Effective April 6, 2022

1 month ago - GlobeNewsWire

Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion

SOUTH SAN FRANCISCO, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today announced that its stockholders have voted to approve all of the proposals related to the previou...

1 month ago - GlobeNewsWire

Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casd...

Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022

1 month ago - GlobeNewsWire

Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financi...

Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting

1 month ago - GlobeNewsWire

Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022

Provides Stockholders Additional Time to Consider $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors Provides Stockholders Additional Time to Consider $250 Million S...

1 month ago - GlobeNewsWire

Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY

Cash Investment Expected to Significantly Advance Fluidigm's Mission through New Growth Initiatives and Cost Structure Optimization Cash Investment Expected to Significantly Advance Fluidigm's Mission t...

1 month ago - GlobeNewsWire

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals...

Fluidigm Board of Directors Unanimously Recommends Stockholders Vote “FOR” ALL Proposals TODAY Fluidigm Board of Directors Unanimously Recommends Stockholders Vote “FOR” ALL Proposals TODAY

2 months ago - GlobeNewsWire

Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...

3 months ago - GlobeNewsWire

Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital...

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today filed with the U.S. Securities and Exchange Commission (the “SEC”) a preliminary proxy statement f...

3 months ago - GlobeNewsWire

Casdin Capital, Viking Global Investors Inject $250M In Fluidigm

Fluidigm Corporation (NASDAQ: FLDM) has approved a $250 million investment by Casdin Capital LLC and Viking Global Investors LP with zero-coupon convertible preferred shares with a conversion price of $...

3 months ago - Benzinga

Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebran...

Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions

3 months ago - GlobeNewsWire

Fluidigm Shares Gain As Preliminary Q4, FY21 Sales Exceed Expectations

Fluidigm Corp (NASDAQ: FLDM) expects Q4 FY21 sales of $38.0 million - $38.3 million, exceeding the company's prior guidance of $31 million – $34 million and the analyst estimate of $32.7 million. Base p...

4 months ago - Benzinga

Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company's Biomark Platform Detects Omicron Variant of COV...

No Published Viral Mutations to Date, Including Omicron Variant, Meaningfully Impact the Regions of the Viral Genome Targeted by the Assay No Published Viral Mutations to Date, Including Omicron Variant...

5 months ago - GlobeNewsWire

Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health i...

6 months ago - GlobeNewsWire

Hot Penny Stocks To Buy Now? 4 To Add To Your List Today

Are these on your list of penny stocks to watch today? The post Hot Penny Stocks To Buy Now?

Other symbols:DXFGLYCGRNQ
6 months ago - PennyStocks

Biomark X Offers Industry-Leading Advantages in Speed, Throughput, Flexibility and Cost

Streamlines Operations to Reduce Hands-On Time, Accelerate Results

6 months ago - GlobeNewsWire

Fluidigm Q3 Sales Trail Estimates; Cuts Annual Guidance As COVID-19 Sales Retreat

Fluidigm Corp (NASDAQ: FLDM) posted Q3 revenues of $28.5 million, down 29% Y/Y, missing the consensus of $30.00 million, citing supply chain issues affecting product fulfillment. Fluidigm is undertaking...

6 months ago - Benzinga

Fluidigm Announces Third Quarter 2021 Financial Results

Board Undertaking Review of Range of Value-Enhancing Opportunities

6 months ago - GlobeNewsWire

Imaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and P...

IMC Studies Part of New York Genome Center's Polyethnic-1000 Initiative Advancing Understanding of Racial Disparities in the Prevalence of Cancer Types IMC Studies Part of New York Genome Center's Polye...

6 months ago - GlobeNewsWire

Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results

SOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health i...

6 months ago - GlobeNewsWire